Andreea M. Bujor, MD, PhD

Associate Professor, Medicine

Andreea Bujor
617.638.4312
75 E. Newton St Evans Building

Other Positions

  • Associate Program Director, Rheumatology Fellowship Program, Arthritis & Autoimmune Diseases Research Center, Boston University
  • Member, Evans Center for Interdisciplinary Biomedical Research, Boston University

Education

  • Iuliu Hațieganu University of Medicine and Pharmacy, MD
  • Iuliu Hațieganu University of Medicine and Pharmacy, PhD
  • Iuliu Hațieganu University of Medicine and Pharmacy, MS

Publications

  • Published on 12/19/2023

    Lui JK, Cozzolino M, Winburn M, Trojanowski MA, Wiener RS, LaValley MP, Bujor AM, Gopal DM, Klings ES. Role of Left Ventricular Dysfunction in Systemic Sclerosis-Related Pulmonary Hypertension. Chest. 2023 Dec 19. PMID: 38128607.

    Read at: PubMed
  • Published on 11/13/2023

    Lui JK, Gillmeyer KR, Sangani RA, Smyth RJ, Gopal DM, Trojanowski MA, Bujor AM, Soylemez Wiener R, LaValley MP, Klings ES. A Clinical Decision Tool for Risk Stratifying Patients with Systemic Sclerosis-Related Pulmonary Hypertension. Lung. 2023 Dec; 201(6):565-569. PMID: 37957388.

    Read at: PubMed
  • Published on 6/17/2023

    Vakhshoorzadeh J, Lui JK, Sangani RA, Trojanowski MA, Bujor AM, LaValley MP, Klings ES. Emphysema and interstitial lung disease in systemic sclerosis-related pulmonary hypertension. Respir Med. 2023 Sep; 216:107333. PMID: 37336329.

    Read at: PubMed
  • Published on 5/25/2023

    Pilvar A, Mehendale AM, Karrobi K, El-Adili F, Bujor A, Roblyer D. Spatial frequency domain imaging for the assessment of scleroderma skin involvement. Biomed Opt Express. 2023 Jun 01; 14(6):2955-2968. PMID: 37342706.

    Read at: PubMed
  • Published on 1/23/2023

    El-Adili F, Lui JK, Najem M, Farina G, Trojanowska M, Sam F, Bujor AM. Correction: Periostin overexpression in scleroderma cardiac tissue and its utility as a marker for disease complications. Arthritis Res Ther. 2023 Jan 23; 25(1):11. PMID: 36691037.

    Read at: PubMed
  • Published on 1/20/2023

    Lui JK, Sangani RA, Gillmeyer KR, Vakhshoorzadeh J, Trojanowski MA, Bujor AM, Gopal DM, Wiener RS, LaValley MP, Klings ES. Correction to: Hemodynamic Response to Oral Vasodilator Therapy in Systemic Sclerosis-Related Pulmonary Hypertension. Cardiovasc Drugs Ther. 2023 Jan 20. PMID: 36662449.

    Read at: PubMed
  • Published on 1/20/2023

    Raslan AA, Pham TX, Lee J, Hong J, Schmottlach J, Nicolas K, Dinc T, Bujor AM, Caporarello N, Thiriot A, von Andrian UH, Huang SK, Nicosia RF, Trojanowska M, Varelas X, Ligresti G. Single Cell Transcriptomics of Fibrotic Lungs Unveils Aging-associated Alterations in Endothelial and Epithelial Cell Regeneration. bioRxiv. 2023 Jan 20. PMID: 36712020.

    Read at: PubMed
  • Published on 1/19/2023

    Browning JL, Bhawan J, Tseng A, Crossland N, Bujor AM, Akassoglou K, Assassi S, Skaug B, Ho J. Extensive and Persistent Extravascular Dermal Fibrin Deposition Characterizes Systemic Sclerosis. bioRxiv. 2023 Jan 19. PMID: 36711912.

    Read at: PubMed
  • Published on 1/18/2023

    Lui JK, Gillmeyer KR, Sangani RA, Smyth RJ, Gopal DM, Trojanowski MA, Bujor AM, Soylemez Wiener R, LaValley MP, Klings ES. A Multimodal Prediction Model for Diagnosing Pulmonary Hypertension in Systemic Sclerosis. Arthritis Care Res (Hoboken). 2023 Jul; 75(7):1462-1468. PMID: 35678779.

    Read at: PubMed
  • Published on 1/6/2023

    Lui JK, Sangani RA, Gillmeyer KR, Vakhshoorzadeh J, Trojanowski MA, Bujor AM, Gopal DM, Wiener RS, LaValley MP, Klings ES. Hemodynamic Response to Oral Vasodilator Therapy in Systemic Sclerosis-Related Pulmonary Hypertension. Cardiovasc Drugs Ther. 2023 Jan 06. PMID: 36607535.

    Read at: PubMed

View 29 more publications: View full profile at BUMC

View all profiles